Research Topics
| Luigi BartalenaSummaryCountry: Italy Publications
| Collaborators
|
Detail Information
Publications
Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challengeLuigi Bartalena
University of Insubria, Varese, Italy
Clin Endocrinol (Oxf) 56:23-4. 2002
An update on medical management of Graves' ophthalmopathyL Bartalena
Department of Clinical Medicine, University of Insubria, Varese, Italy
J Endocrinol Invest 28:469-78. 2005..Antioxidants might have a role, at least in mild forms of GO. Particular attention should be paid to correction of risk factors (cigarette smoking, thyroid dysfunction, radioiodine therapy) involved in GO progression...
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?Maria Laura Tanda
Division of Endocrinology, Department of Clinical Medicine, University of Insubria, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
Eur J Endocrinol 159:359-61. 2008
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathyLuigi Bartalena
Department of Clinical Medicine, University of Insubria, Varese, Italy
Thyroid 18:333-46. 2008
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GOLuigi Bartalena
Department of Clinical Medicine, University of Insubria, 21100 Varese, Italy
Eur J Endocrinol 158:273-85. 2008
Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implicationsLuigi Bartalena
Division of Endocrinology, University of Insubria, Varese, Italy
Biofactors 19:155-63. 2003..It currently seems unlikely that they may find a relevant place in the limited armamentarium available for the management of severe GO...
Relationship between management of hyperthyroidism and course of the ophthalmopathyL Bartalena
Department of Clinical Medicine, Division of Endocrinology, University of Insubria, Varese, Italy
J Endocrinol Invest 27:288-94. 2004..The authors' preference goes to the former, because it depletes intrathyroidal autoreactive T lymphocytes and removes thyroid antigens, which are likely to be involved in the pathogenesis of autoimmune reactions of the ophthalmopathy...
Graves' ophthalmopathy: state of the art and perspectivesL Bartalena
Department of Clinical Medicine, University of Insubria, Varese, Italy
J Endocrinol Invest 27:295-301. 2004..Cessation of smoking currently represents the only form of GO (secondary and tertiary) prevention...
The role of somatostatin analogs in the management of Graves' ophthalmopathyL Bartalena
Division of Endocrinology, University of Insubria, Varese, Italy
J Endocrinol Invest 26:109-13. 2003
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid AssociationLuigi Bartalena
Division of Endocrinology, University of Insubria, Varese, Italy
Clin Endocrinol (Oxf) 61:494-502. 2004..To determine how expert European thyroidologists assess and treat amiodarone-induced thyrotoxicosis (AIT)...
An update on the pharmacological management of hyperthyroidism due to Graves' diseaseLuigi Bartalena
Division of Endocrinology, Department of Clinical Medicine, Ospedale di Circolo, University of Insubria, Viale Borri, 57, 21100 Varese, Italy
Expert Opin Pharmacother 6:851-61. 2005..Neither one has clear advantages in terms of outcome but the latter method is associated with more frequent side effects. Hyperthyroidism relapses in approximately 50% of patients, to whom ablative therapy should be offered...
Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidismLuigi Bartalena
Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
Eur J Endocrinol 153:13-4. 2005
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep tryingL Bartalena
Section of Endocrinology, Department of Clinical Medicine, University of Insubria, Varese, Italy
J Endocrinol Invest 29:1012-6. 2006
Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?L Bartalena
Department of Endocrinology, University of Insubria, Varese, Italy
J Endocrinol Invest 26:5-16. 2003..It is recommended that a large, multi-center, prospective, randomized and controlled study with well defined inclusion criteria be carried out to draw sound conclusions on the role of OR in the management of Graves' ophthalmopathy...
Novel immunomodulating agents for Graves orbitopathyLuigi Bartalena
Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Varese, Italy
Ophthal Plast Reconstr Surg 24:251-6. 2008
Graves' ophthalmopathy: a preventable disease?Luigi Bartalena
Cattedra di Endocrinologia, University of Insubria, Varese, Italy
Eur J Endocrinol 146:457-61. 2002....
Orbital radiotherapy for Graves' ophthalmopathyLuigi Bartalena
Cattedra di Endocrinologia, University of Insubria, Varese, Italy
Thyroid 12:245-50. 2002..g., in patients with diabetes) is a contraindication to this treatment for the risk of further retinal damage. No case of radiation-induced tumors has so far been described after orbital radiotherapy for Graves' ophthalmopathy...
Management of thyroid eye diseaseLuigi Bartalena
Department of Endocrinology, University of Insubria, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
Eur J Nucl Med Mol Imaging 29:S458-65. 2002..A coordinated approach to the treatment of hyperthyroidism and TED is also required. Novel promising treatments, to be verified in large series of patients, include somatostatin analogues and cytokine antagonists...
Perspectives in pharmacological management of Graves' hyperthyroidism and orbitopathyLuigi Bartalena
Professor, Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
Expert Rev Clin Immunol 4:321-9. 2008....
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort studyAdriana Lai
Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
J Clin Endocrinol Metab 95:1333-7. 2010..2 mg/kg bw) are as effective as previously reported doses (0.3-0.5 mg/kg bw). A shorter treatment period (6 wk) is probably sufficient. The increase in bw is less using lower doses of prednisone...
Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoidsFrancesca Menconi
Department of Endocrinology, University of Pisa, Via Paradisa 2, 56100 Pisa, Italy
J Clin Endocrinol Metab 92:1653-8. 2007..Total thyroid ablation (TTA) may be beneficial for GO through removal of shared antigen(s) and autoreactive T-lymphocytes, but randomized studies are lacking...
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologistsMaria Laura Tanda
Department of Clinical Medicine, University of Insubria, Varese, Italy
Clin Endocrinol (Oxf) 69:812-8. 2008..To investigate how North American thyroidologists assess and treat amiodarone-induced thyrotoxicosis (AIT) and to compare the results with those of the same questionnaire-based survey previously carried out among European thyroidologists...
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrationsFausto Bogazzi
Department of Endocrinology, University of Pisa, Ospedale Cisanello, Via Paradisa, 2, 56124 Pisa, Italy
J Clin Endocrinol Metab 92:556-62. 2007..Amiodarone-induced thyrotoxicosis (AIT) resulting from destructive thyroiditis (type 2) is commonly treated with glucocorticoids, but time needed to restore euthyroidism may be unacceptable for patients with underlying cardiac disorders...
Novel treatment modalities for Graves' orbitopathyLuigi Bartalena
Departments of Clinical Medicine and Surgical Sciences, University of Insubria, Division of Endocrinology, Varese, Italy
Pediatr Endocrinol Rev 7:210-6. 2010..However, randomized, controlled clinical trials to support their use are warranted...
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatmentLuigina Guasti
Department of Clinical Medicine, University of Insubria, Varese, Italy
Clin J Pain 23:518-23. 2007..Moreover, a few experimental studies show that peripheral benzodiazepine receptors (PBRs), which may be altered in hypothyroidism, seem to be related with pain perception...
Approach to the patient with amiodarone-induced thyrotoxicosisFausto Bogazzi
Department of Endocrinology, University of Pisa, Ospedale Cisanello, Via Paradisa, 2, 56124 Pisa, Italy
J Clin Endocrinol Metab 95:2529-35. 2010..RAI is usually not feasible in AIT due to low RAI uptake values. Thyroidectomy represents a valid option in cases resistant to medical therapy...
Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective studyGianlorenzo Dionigi
Endocrine Surgery Research Center, Department of Surgical Sciences, University of Insubria, Varese, Italy
Am J Surg 197:434-8. 2009..The aim of the current study was to evaluate the time interval (TI) required for the diagnosis of symptomatic papillary thyroid carcinoma (PTC)...
Shortening hospital stay for thyroid surgeryGianlorenzo Dionigi
Department of Surgical Sciences, Medical School, University of Insubria, Italy
Expert Rev Med Devices 5:85-96. 2008..We discuss the special ethical and legal issues that this thyroid surgery raises. Searches were last updated in May 2007...
Medullary thyroid carcinoma: surgical treatment advancesGianlorenzo Dionigi
Department of Surgical Sciences, University of Insubria, Azienda Ospedaliero Universitario, Fondazione Macchi 57, Varese, Italy
Expert Rev Anticancer Ther 7:877-85. 2007..We discuss the particular ethical and legal issues that thyroid prophylactic surgery raises. Searches were last updated in February 2007...
Nodule size and fine-needle aspiration biopsy: diagnostic challenges for thyroid malignancyStefano Rausei
Department of Surgical Sciences, University of Insubria, Borri, Italian Republic, Varese, Italy
Am J Surg 201:525-30. 2011..To investigate the relationship between nodule size and malignancy and the correlation between the dimensional parameter and fine-needle aspiration biopsy (FNAB) in patients with a nodular goiter...
Simultaneous medullary and papillary thyroid cancer: two case reportsGianlorenzo Dionigi
Department of Surgical Sciences, University of Insubria, Varese, Italy
J Med Case Reports 1:133. 2007..Papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) have always been considered different from each other; in their incidence, their cell origin and their histopathological features...
The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathyLuigi Bartalena
Department of Clinical Medicine, University of Insubria, Endocrinology Unit, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
J Clin Endocrinol Metab 96:592-9. 2011..Whether antithyroid drugs (ATDs), radioactive iodine (RAI), or thyroidectomy should be the treatment of choice in the presence of overt and active GO is a matter of debate...
Long-term safety of orbital radiotherapy for Graves' ophthalmopathyClaudio Marcocci
Department of Endocrinology, University of Pisa, 56124 Pisa, Italy
J Clin Endocrinol Metab 88:3561-6. 2003..Although no secondary tumors were detected, due to the long latency of radiation-induced tumors, OR should be restricted to patients older than 35 yr...
Prevention of Graves' ophthalmopathyLuigi Bartalena
Department of Clinical and Experimental Medicine, University of Insubria, Endocrine Unit, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
Best Pract Res Clin Endocrinol Metab 26:371-9. 2012..If radioiodine is used, low-dose steroid prophylaxis is recommended, particularly in smokers, to prevent radioiodine-associated GO progression...
What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?Luigi Bartalena
Department of Clinical Medicine, University of Insubria, Division of Endocrinology, Ospedale di Circolo, Varese, Italy
Clin Endocrinol (Oxf) 73:149-52. 2010..The use of biological agents, the most promising being rituximab, is for the time being experimental and warrants support from randomized clinical trials...
Efficacy and safety of orbital radiotherapy for graves' orbitopathyMaria Laura Tanda
Department of Clinical, Experimental Medicine, University of Insubria, Endocrine Unit, Ospedale di Circolo, Viale Borri, 57, 21100 Varese, Italy
J Clin Endocrinol Metab 97:3857-65. 2012..High-dose glucocorticoids (GCs) represent the first-line treatment. Orbital radiotherapy (OR) has been used for decades, alone or in combination with GCs, but opinions on its efficacy are conflicting...
Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapyFranca Marino
Department of Clinical Medicine, Section of Experimental and Clinical Pharmacology, University of Insubria, Via Ottorino Rossi n. 9, 21100 Varese VA, Italy
Life Sci 78:1071-7. 2006..The present results document the existence of a correlation between thyroid status and oxidative metabolism of human PMNs, which is however unlikely to depend upon a direct action of thyroid hormones on these cells...
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional studyAlessandro Squizzato
Department of Clinical Medicine, University of Insubria, Ospedale di Circolo, Viale Borri 57, 21100 Varese, Italy
Thromb Haemost 97:803-6. 2007..The results of this pilot study suggest an increased prevalence of subclinical hypothyroidism in patients with unDVT. The clinical relevance of these preliminary findings needs to be addressed in larger prospective studies...
Surgery of lymph nodes in papillary thyroid cancerGianlorenzo Dionigi
Department of Surgical Sciences, Medical School, University of Insubria, Viale Borri 57, 21100, Varese, Italy
Expert Rev Anticancer Ther 6:1217-29. 2006..This paper reviews relevant medical literature published in the English language on surgery of lymph nodes in differentiated thyroid cancer with well-controlled trials. Searches were last updated in June 2006...
Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's diseaseFausto Bogazzi
Department of Endocrinology, University of Pisa, Italy
Clin Endocrinol (Oxf) 66:7-12. 2007..Peroxisome proliferators-activated receptor (PPAR)gamma is the master regulator of adipogenesis; however, the expression of PPARgamma isoforms in the subcutaneous adipose tissue (SAT) of patients with Cushing's disease is unknown...
Adjuvant effect of lithium on radioiodine treatment of hyperthyroidismFausto Bogazzi
Thyroid 12:1153-4. 2002
Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomyFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Cisanello Hospital, Via Paradisa 2, 56124 Pisa, Italy
Surgery 132:1114-7; discussion 1118. 2002..None had increased surgical bleeding, recurrent nerve palsy, or hypoparathyroidism. No cardiovascular complications occurred. CONCLUSIONS: Iopanoic acid is an effective drug allowing rapid control of hyperthyroidism in AIT...
Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized studyFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Italy
J Clin Endocrinol Metab 88:1999-2002. 2003..221 +/- 111 d, respectively, P < 0.002). This study shows that, albeit both drugs are effective, glucocorticoids are probably the drug of choice for more rapidly curing type II AIT...
Current medical management of Graves ophthalmopathyClaudio Marcocci
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
Ophthal Plast Reconstr Surg 18:402-8. 2002
Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' diseaseFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, 56124 Pisa, Italy
J Clin Endocrinol Metab 87:4490-5. 2002..Accordingly, a short course of lithium therapy can be considered a useful adjunct to RAI therapy to obtain a prompter control of thyrotoxicosis and avoid its transient exacerbation because of MMI withdrawal and RAI administration...
Thyroid vascularity is increased in patients with active acromegalyFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Italy
Clin Endocrinol (Oxf) 57:65-70. 2002..To determine whether acromegalic patients have increased thyroidal vascularity and blood flow on colour flow Doppler sonography (CFDS)...
Radioiodine therapy and Graves' ophthalmopathyLuigi Bartalena
Nucl Med Commun 23:1143-5. 2002
Orbital radiotherapy for Graves' ophthalmopathyLuigi Bartalena
J Clin Endocrinol Metab 89:13-4. 2004
Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic surveyLeandro Arthur Diehl
Londrina State University, Brazil
Clin Endocrinol (Oxf) 65:433-8. 2006..To assess diagnostic and therapeutic approaches to amiodarone-induced thyrotoxicosis (AIT) among members of the Latin American Thyroid Society (LATS)...
Editorial: glucocorticoids for Graves' ophthalmopathy: how and whenLuigi Bartalena
J Clin Endocrinol Metab 90:5497-9. 2005
Orbital decompression in graves' ophthalmopathy by medial and lateral wall removalStefano Sellari-Franceschini
Department of Neuroscience, Ia ENT division, Pisa, Italy
Otolaryngol Head Neck Surg 133:185-9. 2005..The objective of this study is to describe a technique for balanced orbital decompression and to analyze the results...
Treatment with thionamides before radioiodine therapy for hyperthyroidism: yes or no?Luigi Bartalena
J Clin Endocrinol Metab 90:1256; author reply 1256-7. 2005
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in ItalyFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
Clin Endocrinol (Oxf) 67:533-7. 2007..Type 2 AIT is a destructive thyroiditis, responds to glucocorticoids, and usually does not require further thyroid treatment once euthyroidism has been restored...
Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet?Luigi Bartalena
J Clin Endocrinol Metab 89:5908-9. 2004
Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormoneFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
Thyroid 16:989-95. 2006..Thyrotropin (TSH)-secreting pituitary adenoma (TSHoma) and resistance to thyroid hormone (RTH) are two forms of inappropriate TSH secretion. Thyroid blood flow is largely TSH dependent...
Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patientsFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
J Clin Endocrinol Metab 87:2403-6. 2002..03). In conclusion, patients with active Acro have a reduced expression of PPARgamma in the colonic mucosa, which appears be related to the increased serum IGF-I levels and might lead to an increased prevalence of colonic polyps...
Smoking and Graves' diseaseLuigi Bartalena
J Endocrinol Invest 25:402. 2002
Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GHFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Ospedale Cisanello, Via Paradisa 2, 56124 Pisa, Italy
J Endocrinol 194:521-7. 2007..This study demonstrated a direct effect of GH on key proteins involved in energy metabolism of acromegalic hearts...
Orbital radiation therapy for Graves' ophthalmopathyLuigi Bartalena
Ophthalmology 110:452-3; author reply 453-4. 2003
Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseasesLuca Manetti
Dipartimento di Endocrinologia, Universita di Pisa, Ospedale Cisanello, Via Paradisa, 2, Pisa, Italy
J Clin Endocrinol Metab 92:2176-81. 2007..Circulating antipituitary antibodies (APA) are markers of autoimmune hypophysitis, which may cause deficient pituitary function. The prevalence of APA in autoimmune thyroid disorders (AITD) is uncertain...
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre studyArmando Bartolazzi
Department of Pathology, St Andrea University Hospital, Rome, Italy
Lancet Oncol 9:543-9. 2008..We aimed to assess the diagnostic effect of galectin-3 expression analysis in distinguishing preoperatively benign from malignant follicular thyroid nodules when FNA findings were indeterminate...
Apoptosis is reduced in the colonic mucosa of patients with acromegalyFausto Bogazzi
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
Clin Endocrinol (Oxf) 63:683-8. 2005..GH and IGF-1 decrease apoptosis in several cell lines including human colonic adenocarcinoma, but it is unknown whether epithelial cells of colonic mucosa of patients with acromegaly have reduced apoptosis...
Epidemiology and prevention of Graves' ophthalmopathyWilmar M Wiersinga
Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Thyroid 12:855-60. 2002..Smoking withdrawal may increase the effectiveness of immunosuppressive treatment...
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathyMichele Marino
Thyroid 14:403-6. 2004
